Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02753387Phase 3Completed
Phase 3, randomised trial of chlorhexidine in surgical site infection (SSI) (2 arms), sponsored by CHU Rennes. Primary endpoint: Percentage of patients with pharyngeal mucosa colonization. Started May 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02753387.